Efficacy of pergolide in treatment of restless legs syndrome: The PEARLS Study
Neurology Trenkwalder et al.
62: 1391
Data supplement
Six tables; one Word document.
Files in this Data Supplement:
E1-E6
-
Table 1: IRLS severity scale; Table 2: Baseline characteristics of the patients; Table 3: Treatment effects of pergolide (mean dose, 0.40 mg/day) and placebo after 6 weeks; Table 4: Treatment effects of pergolide and placebo at one year; Table 5: Treatment-emergent adverse events reported during the first 6 weeks; Table 6: Treatment-emergent adverse events reported during the entire 12-month study period; Word document.